Beta-lactamase-mediated antibiotic resistance continues to challenge the contemporary treatment of serious bacterial infections. The KPC-2 beta-lactamase, a rapidly emerging gram-negative resistance determinant, hydrolyzes all commercially available beta-lactams, including carbapenems and beta-lacta...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!